Podcast · Business & Entrepreneuriat
Executive Edge Podcast
By Executive Edge, Podcast Host at Executive Edge
A global interview platform featuring C-suite executives, operational leaders, and strategic thinkers shaping modern business across industries.
⏱ 8 min read · Readable by ChatGPT, Gemini, Claude
Answers from this podcast
18 questions answered · 3 episodes indexed
Drug Development Is a Team Sport — And Procurement Has to Play.
The FDA has a very structured pipeline with core drug discovery in the laboratory, preclinical testing involving animal testing for safety and toxicity, and then clinical trials with three main phases.
CROs are professional service firms with staff including PhDs and highly skilled people who understand how to run tests in both preclinical areas focusing on animal testing and in human trials.
Companies may scale spending from $20 million annually to $40 million, then $80 million, $100 million, and potentially $200 million per year in drug development.
Viagra was initially designed for heart treatment more than 20 years ago, but during trials it showed different indications that led to a different marketplace and different aspect of human health.
Procurement must actively seek out R&D staff through coffee meetings and lunches to listen and understand their needs rather than waiting for them to approach.
If costs get out of hand, the company will lose money and might experience failures. In very risky early-stage investments, this can mean bankruptcy.
The Risk Is Always There: How to Get Ahead of Supply Disruption
Supply chain risk monitoring became increasingly essential following major global disruptions over the past 25-26 years since the early 2000s, including the 2004-2005 tsunami in Asia, the Great Recession, Brexit, and especially COVID-19, which was completely unparalleled and unprecedented.
For any organization to survive and function, if you do not get the supplier and sourcing DNA right, your top line as well as your bottom line goes for a toss.
Leading organizations are implementing three main use cases: first, monitoring strategic suppliers to identify hidden or inherent business risks; second, conducting due diligence and detailed risk assessments even before issuing an RFI with suppliers; and third, event-driven exercises triggered either by…
Organizations are shifting from purely reactive, historical data-based risk monitoring to forward-looking approaches by predicting changes likely to happen with suppliers over 6, 12, or 18 months.
Organizations should screen for red flags including: whether a director or board member is from a country with economic sanctions, whether the company filed for bankruptcy in the last 12-24 months, high debt levels, recent acquisitions (3-6 months prior to RFI), and in the pharma sector, whether the FDA has…
Companies should segment suppliers not primarily by spend, but by linking the supplier to revenue impact—specifically to the business unit, brand, or SKU sold to the end customer.
Why Procurement Can Make or Break a Drug Company
The CDMO marketplace is hundreds of billions in total, and biologics manufacturing is forecasted to grow at a compound annual growth rate of 8 to 12% over the next seven years, reflecting rapid growth in the global manufacturing of these drugs.
About 37% of the chemicals used as key starting materials are globally sourced out of China and may then be shipped to another CDMO that makes the active pharmaceutical ingredient, which could be in Europe, the U.S., or Japan.
The development process is not something that happens in six to 12 months; it typically takes years—two to five to 10 years—as you develop the drug through clinical trials and scale production.
The FDA publishes 483 reports documenting citations for issues CDMOs have been cited for that they must fix before going into production. Additionally, quality and regulatory professionals can observe how well CDMOs document and track information in their systems during sourcing events.
Key starting materials (KSMs) are chemicals that go into an active pharmaceutical ingredient (API); they typically originate in China, move to a CDMO for API production in Europe, the U.S., or Japan, then progress to dosage form manufacturing, primary and secondary packaging, and finally distribution.
The CDMO location is critical because it affects logistics parameters like cold chain requirements, transport time, and half-life stability of the drug.
What Executive Edge Podcast covers
Executive Edge brings together the world's most accomplished business leaders for direct, unfiltered conversations about strategy, operations, and the future. The podcast explores how procurement shapes pharmaceutical outcomes, how supply disruption tests organizational resilience, and why AI adoption is becoming an existential challenge for competitive advantage. Each episode distills decades of boardroom experience into actionable perspectives on hiring, team dynamics, and executing vision at scale.
Key facts
- Procurement strategy directly determines drug development success, timelines, and regulatory compliance in pharmaceutical organizations.
- Supply chain disruption is not a rare event but an ongoing operational reality that separates leaders who plan proactively from those who react.
- AI adoption is reshaping hiring practices, work design, and operational efficiency—companies that integrate AI early gain structural competitive advantage.
- Effective leadership across industries requires team-based execution, dynamic work design, and hiring practices that evaluate capability beyond credentials.
Get deeper insights by exploring all episodes of Executive Edge Podcast.
What this podcast really covers
Executive Edge goes beyond surface-level business commentary. It examines the operational infrastructure that separates thriving companies from those struggling to compete. The podcast anchors its interviews in concrete challenges: how a drug company's procurement team can either accelerate or stall clinical development, how supply chains fail silently until they catastrophically collapse, and how AI tools force executives to rethink hiring, work processes, and organizational design.
These are not theoretical discussions. Each interview draws from real executive experience managing complexity, navigating trade-offs, and building resilient organizations. The podcast reveals how leadership in procurement, operations, and strategy actually works—not as aspirational principle, but as daily problem-solving under uncertainty.
Who this podcast is essential for
Chief Procurement Officers and Supply Chain Leaders gain tactical insights into pharmaceutical procurement strategy, supplier management, and how procurement teams can drive competitive advantage rather than act as cost centers. The podcast demonstrates how procurement expertise translates directly to product delivery, regulatory success, and bottom-line impact.
Executives in Life Sciences and Pharma learn how procurement, R&D, and manufacturing must operate as an integrated system. The podcast addresses the specific challenges of drug development timelines, regulatory complexity, and global supply chain risk unique to the industry.
Business Leaders and Entrepreneurs Across Sectors extract principles on hiring, team design, AI adoption, and execution strategy that apply universally. The podcast shows how leaders in different industries solve similar problems—building adaptive organizations, managing disruption, and translating vision into sustained performance.
What the episodes really reveal
The episode catalog reveals a consistent focus on operational leadership and strategic resilience. Recurring themes include the hidden importance of procurement in competitive strategy, supply chain vulnerability as an existential risk, and the necessity of human-centered team design in an AI-driven world. The podcast returns repeatedly to hiring practices, emphasizing that great leaders are identified through behavioral assessment and past performance, not credentials. Another pattern: the emphasis on cross-functional integration. Successful drug development, effective supply chain management, and sustainable competitive advantage all require procurement, operations, finance, and strategy to function as a single system rather than separate departments.
The podcast also grapples with future-oriented challenges. Multiple episodes explore how AI adoption separates leading organizations from those falling behind, how global trade and geopolitics reshape supply strategy, and how work design must evolve to remain productive and human-centered as automation increases.
What this changes in practice
Organizations listening to Executive Edge should reconsider how they structure procurement and supply chain teams. If procurement operates as a cost-reduction function isolated from product strategy, the company is missing competitive advantage. Instead, procurement should be integrated into product development and strategic planning from conception. Supply chain resilience requires ongoing scenario planning, supplier relationship investment, and inventory strategy—not crisis response after disruption occurs. Hiring practices should shift away from resume-based selection toward behavioral assessment, reference conversations that evaluate past team-building and problem-solving, and cultural alignment evaluation. Finally, AI adoption should be strategic and intentional—neither ignored nor implemented reactively. Leaders who articulate where AI augments human capability and where human judgment remains essential will build organizations that scale effectively.
Executive Edge demonstrates that operational excellence—procurement, supply chain, hiring, and team design—is not administrative infrastructure but the foundation of competitive strategy. Organizations that build deep expertise in these areas consistently outexecute competitors in market speed, resilience, and profitability.
Listen to all episodes and discover how global leaders build competitive advantage.
The podcast answers these questions
How do procurement strategies impact pharmaceutical company success?
Procurement decisions directly influence drug development timelines, cost structures, and supply chain resilience. Companies that integrate procurement early into product strategy gain competitive advantage through better supplier relationships, reduced delays, and improved regulatory compliance. Strategic procurement alignment with R&D and manufacturing teams determines whether a company can deliver drugs to market efficiently and sustainably.
What role does AI play in modern business leadership?
AI is reshaping how executives approach decision-making, workforce planning, and operational efficiency. Leaders who adopt AI technologies early position their organizations to adapt faster to market changes. However, human judgment, ethical frameworks, and strategic vision remain irreplaceable—AI augments leadership capability rather than replacing it.
How can organizations prepare for supply chain disruption?
Proactive supply chain management requires scenario planning, supplier diversification, inventory optimization, and real-time visibility systems. Organizations that build redundancy and maintain strong relationships with multiple suppliers recover faster from disruptions. Continuous monitoring and adaptive strategies help executives stay ahead of market volatility.
What makes effective hiring practices for leadership roles?
Great leaders are hired through behavioral assessment, track record analysis, and cultural alignment evaluation—not resume screening alone. Organizations must evaluate problem-solving capability, team-building history, and adaptability to organizational context. Reference conversations and scenario-based interviews reveal leadership potential beyond credentials.
Start listening to Executive Edge Podcast episodes now.
Discover Executive Edge Podcast
Executive Edge · Global interviews with business leaders
Listen to the podcast